Since dendritic spine remodeling correlates with the cognitive performance of an animal (31, 32), it is reasonable to believe that tau-mediated dysregulation of these subcellular structures may contribute to the cognitive decline of patients with tauopathies. The gene discussed is MAPT; the disease is tauopathy.